ARPC4
Actin-related protein 2/3 complex subunit 4
Also known as: ARC20, ARPC4_HUMAN, p20-Arc
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P59998
- Gene
- ARPC4
- Ensembl
- ENSG00000241553
- Chromosome
- 3
- Canonical length
- 168 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes one of seven subunits of the human Arp2/3 protein complex. This complex controls actin polymerization in cells and has been conserved throughout eukaryotic evolution. This gene encodes the p20 subunit, which is necessary for actin nucleation and high-affinity binding to F-actin. Alternative splicing results in multiple transcript variants. Naturally occurring read-through transcription exists between this gene and the downstream tubulin tyrosine ligase-like family, member 3 (TTLL3), which results in the production of a fusion protein. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
168 residues, UniProt reviewed canonical sequence.
>P59998|ARPC4
1 MTATLRPYLS AVRATLQAAL CLENFSSQVV ERHNKPEVEV RSSKELLLQP VTISRNEKEK
61 VLIEGSINSV RVSIAVKQAD EIEKILCHKF MRFMMMRAEN FFILRRKPVE GYDISFLITN
121 FHTEQMYKHK LVDFVIHFME EIDKEISEMK LSVNARARIV AEEFLKNFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARPC4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 192 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 192 nTPM
- spleen: 165 nTPM
- lymph node: 160 nTPM
- esophagus: 158 nTPM
- blood vessel: 142 nTPM
- bone marrow: 140 nTPM
Single-cell type
- megakaryocytes: 43 nCPM
- microglia: 36 nCPM
- platelets: 28 nCPM
- cardiomyocytes: 23 nCPM
- oligodendrocytes: 21 nCPM
- other brain neurons: 21 nCPM
Immune cell
- neutrophil: 642 nTPM
- total PBMC: 481 nTPM
- intermediate monocyte: 470 nTPM
- non-classical monocyte: 461 nTPM
- eosinophil: 434 nTPM
- plasmacytoid DC: 434 nTPM
Brain region
- hippocampal formation: 128 nTPM
- thalamus: 121 nTPM
- pons: 104 nTPM
- cerebral cortex: 104 nTPM
- white matter: 104 nTPM
- hypothalamus: 103 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARPC4.
Disease | AllUniProt
Conditions ARPC4 is implicated in, by any mechanism.
- Developmental delay, language impairment, and ocular abnormalities (DEVLO) MIM:620141
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.21
- DepMap mean gene effect
- -0.67
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Arp2/3 complex subunit 2/4
- Actin-related protein 2/3 complex subunit 4
- ARP2/3 complex 20 kDa subunit (ARPC4)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARPC4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARPC4 as an antibody target. Whether an autoantibody or antibody against ARPC4 could matter depends on whether native ARPC4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARPC4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARPC4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...